Study (n) | Participants (n) | MD (95% CI) | p Value | I2 (%) | Egger test | |
---|---|---|---|---|---|---|
Body composition | ||||||
Body mass, kg | 9 | 487 | −2.282 (−4.557 to −0.007) | 0.049 | 0 | 0.430 |
Body mass index, kg/m2 | 10 | 540 | −0.690 (−1.425 to 0.045) | 0.066 | 7.1 | 0.231 |
Waist circumference, cm | 4 | 247 | −3.389 (−7.870 to 1.029) | 0.133 | 63.8 | 0.140 |
Fat mass, % | 8 | 493 | −3.491 (−5.747 to −1.235) | 0.002 | 67.9 | 0.014 |
Fat mass, kg | 9 | 519 | −4.337 (−7.147 to −1.528) | 0.002 | 58.2 | 0.179 |
Lean body mass, kg | 9 | 519 | 2.195 (0.204 to 4.186) | 0.031 | 48.2 | 0.051 |
Visceral fat, cm | 7 | 443 | −0.051 (−0.402 to 0.299) | 0.774 | 35.8 | 0.468 |
Subcutaneous fat, cm | 6 | 378 | −0.175 (−0.370 to 0.021) | 0.081 | 6.9 | 0.129 |
Lipids and lipoprotein | ||||||
Total cholesterol, mg/dL | 6 | 406 | −17.59 (−39.95 to 4.767) | 0.123 | 91.4 | 0.346 |
HDL, mg/dL | 6 | 393 | 1.053 (−0.894 to 3.000) | 0.289 | 0 | 0.470 |
LDL, mg/dL | 7 | 438 | −10.20 (−17.97 to −2.433) | 0.010 | 30.8 | 0.066 |
Triglycerides, mg/dL | 7 | 438 | 10.26 (−0.985 to 21.51)* | 0.074 | 46.3 | <0.001 |
Insulin resistance | ||||||
Fasting glucose, mg/dL | 7 | 451 | −0.422 (−1.119 to 0.275) | 0.236 | 87.4 | 0.100 |
Fasting insulin, µU/mL | 6 | 416 | −1.656 (−3.993 to 0.680) | 0.165 | 53.4 | 0.404 |
HOMA-index | 5 | 266 | −0.403 (−1.151 to 0.346) | 0.292 | 63.1 | 0.389 |
Blood pressure | ||||||
Systolic blood pressure, mm Hg | 3 | 215 | −2.907 (−12.12 to 6.311) | 0.537 | 79.5 | 0.173 |
Adipokines | ||||||
Adiponectin, μg/mL | 5 | 263 | 2.591 (1.860 to 3.322) | <0.001 | 0 | 0.055 |
Leptin, μg/mL | 4 | 236 | −6.810 (−13.73 to 0.107) | 0.054 | 54.9 | 0.091 |
*Positive MD indicates values that favour AT group; all other values indicate results that favour concurrent exercise group.
AE, aerobic training programs; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MD, mean difference.